Literature DB >> 21136081

The potential use of 29 kDa protein as a marker of pathogenicity and diagnosis of symptomatic infections with Blastocystis hominis.

Maha M Abou Gamra1, Hala S Elwakil, Hala K El Deeb, Khalifa E Khalifa, Hala E Abd Elhafiz.   

Abstract

The present study was performed to characterize the protein profiles of Blastocystis hominis isolates from symptomatic and asymptomatic individuals by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting using sera from symptomatic and asymptomatic patients. The presence of immunogenic bands associated with pathogenicity or of diagnostic potentials was also evaluated. The study comprised 80 individuals classified into four groups, 20 each: symptomatic blastocystosis (G1), asymptomatic blastocystosis (G2), other parasitic infections (G3), and healthy control subjects (G4). SDS-PAGE analysis of individual antigens form symptomatic and asymptomatic B. hominis isolates revealed similar and distinctive antigenic bands with significant differences in two high (123.5 and 112.3 kDa) and few low molecular weight bands (48.5, 38, 42.3, and 35.5 kDa). Immunoblotting was performed using symptomatic and asymptomatic antigen pools with sera of the four studied groups. It was found that anti-B. hominis IgG reacted with nine protein bands ranging from 100 to 18 kDa of the symptomatic antigen pool. There was a significant difference between G1 and G2 in the recognition of 64, 56, 38, and 29 kDa antigen bands. Also, anti-B. hominis IgG reacted with five protein bands ranging from 56 to 12 kDa of asymptomatic antigen pool. There was a significant difference between G1 and G2 in the recognition of 29 kDa antigen band. These findings suggest the potential use of the 29-kDa antigen as marker of pathogenicity and implicate its use in the diagnosis and differentiation between symptomatic and asymptomatic blastocystosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21136081     DOI: 10.1007/s00436-010-2156-8

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  36 in total

1.  Experimental Blastocystis hominis infection in laboratory mice.

Authors:  K T Moe; M Singh; J Howe; L C Ho; S W Tan; X Q Chen; G C Ng; E H Yap
Journal:  Parasitol Res       Date:  1997       Impact factor: 2.289

2.  SDS-PAGE and immunological analysis of different axenic Blastocystis hominis strains.

Authors:  K G Kukoschke; H E Müller
Journal:  J Med Microbiol       Date:  1991-07       Impact factor: 2.472

3.  Antibody response to Blastocystis hominis infections.

Authors:  C H Zierdt; B Nagy
Journal:  Ann Intern Med       Date:  1993-06-15       Impact factor: 25.391

4.  Exposure of Blastocystis species to a cytotoxic monoclonal antibody.

Authors:  K S Tan; M Ibrahim; G C Ng; A M Nasirudeen; L C Ho; E H Yap; M Singh
Journal:  Parasitol Res       Date:  2001-07       Impact factor: 2.289

5.  Blastocystis hominis: A simplified, high-efficiency method for clonal growth on solid agar.

Authors:  K S Tan; G C Ng; E Quek; J Howe; N P Ramachandran; E H Yap; M Singh
Journal:  Exp Parasitol       Date:  2000-09       Impact factor: 2.011

6.  Kinetic analysis of antibody responses to Blastocystis hominis in sera and intestinal secretions of orally infected mice.

Authors:  Herbert J Santos; Windell L Rivera
Journal:  Parasitol Res       Date:  2009-07-14       Impact factor: 2.289

7.  Protein profile and morphometry of cultured human Blastocystis hominis from children with gastroenteritis and healthy ones.

Authors:  M M Hegazy; L M Maklouf; E M El Hamshary; H A Dawoud; A M Eida
Journal:  J Egypt Soc Parasitol       Date:  2008-08

8.  Four serologically different groups within the species Blastocystis hominis.

Authors:  H E Müller
Journal:  Zentralbl Bakteriol       Date:  1994-01

9.  Ultrastructure and light microscope appearance of Blastocystis hominis in a patient with enteric disease.

Authors:  C H Zierdt; H K Tan
Journal:  Z Parasitenkd       Date:  1976-10-12

10.  Pathophysiological variability of different genotypes of human Blastocystis hominis Egyptian isolates in experimentally infected rats.

Authors:  Eman M Hussein; Abdalla M Hussein; Mohamed M Eida; Maha M Atwa
Journal:  Parasitol Res       Date:  2008-01-11       Impact factor: 2.289

View more
  9 in total

1.  Blastocystis hominis as a contributing risk factor for development of iron deficiency anemia in pregnant women.

Authors:  Hala K El Deeb; Hesham Salah-Eldin; Seham Khodeer
Journal:  Parasitol Res       Date:  2011-12-14       Impact factor: 2.289

2.  Identification of a Cyclospora cayetanensis Oocyst Antigens and Their Validity in the Detection of Immunogenic Patterns of Cyclosporiasis Patients.

Authors:  Eman M Hussein; Eman K El-Gayar; Ola A Ismail; Amira B Mokhtar; Maha M Al-Abbassy
Journal:  Acta Parasitol       Date:  2020-10-10       Impact factor: 1.440

3.  Blastocystis spp., Cryptosporidium spp., and Entamoeba histolytica exhibit similar symptomatic and epidemiological patterns in healthcare-seeking patients in Karachi.

Authors:  Syeda Sadaf Haider; Rakhshanda Baqai; Fouad M Qureshi; Kenneth Boorom
Journal:  Parasitol Res       Date:  2012-07-05       Impact factor: 2.289

4.  Surface ultrastructure, protein profile and zymography of Blastocystis species isolated from patients with colorectal carcinoma.

Authors:  Mazloum M Ahmed; Fayza S M Habib; Ghada A Saad; Heba M El Naggar
Journal:  J Parasit Dis       Date:  2019-02-05

5.  Variations in active proteases of Blastocystis sp. obtained from water and animal isolates from the Philippines.

Authors:  Davin Edric V Adao; Windell L Rivera
Journal:  J Parasit Dis       Date:  2022-03-17

6.  Blastocystis specific serum immunoglobulin in patients with irritable bowel syndrome (IBS) versus healthy controls.

Authors:  Robyn Nagel; Rebecca J Traub; Marcella M S Kwan; Helle Bielefeldt-Ohmann
Journal:  Parasit Vectors       Date:  2015-09-15       Impact factor: 3.876

7.  Genetic diversity of blastocystis isolated from cattle in khorramabad, iran.

Authors:  Ebrahim Badparva; Javid Sadraee; Farnaz Kheirandish
Journal:  Jundishapur J Microbiol       Date:  2015-01-14       Impact factor: 0.747

8.  Clinical pilot study: efficacy of triple antibiotic therapy in Blastocystis positive irritable bowel syndrome patients.

Authors:  Robyn Nagel; Helle Bielefeldt-Ohmann; Rebecca Traub
Journal:  Gut Pathog       Date:  2014-08-20       Impact factor: 4.181

Review 9.  Update on the pathogenic potential and treatment options for Blastocystis sp.

Authors:  Tamalee Roberts; Damien Stark; John Harkness; John Ellis
Journal:  Gut Pathog       Date:  2014-05-28       Impact factor: 4.181

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.